EUVIMEDEUVIMED entdecken
Vergleichsstudie

Diagnostic Performance and Interpreter Experience of 1-Hour Versus 3-Hour 99m Tc-HMDP Cardiac Amyloid Radionuclide Imaging: A Prospective, Blinded Comparison

Gregorio Tersalvi iD, Patricia Carey iD, Armin Garmany iD, Christopher G Scott iD, Jun Zhang, Francisco J Maldonado, Livia F Kruger iD, Carrie B Hruska iD, Geoffrey B Johnson iD, Hayan Jouni, Martin G Rodriguez-Porcel, J Wells Askew iD und 8 weitere

Circulation: Cardiovascular Imaging · 2026

DOI: 10.1161/circimaging.125.018745 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Circulation: Cardiovascular Imaging, 2026. Verfasst von Gregorio Tersalvi und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine (G.T., H.J., M.G.R.-P., J.W.A., J.P.B., K.A.Y., N.S.A., M.G., P. Chareonthaitawee, O.F.A.), Mayo Clinic, Roches…. Hauptthemen laut MEDLINE: Cardiomyopathies, Radiopharmaceuticals, Amyloid Neuropathies, Familial, Technetium Tc 99m Medronate. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 16 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Guidelines recommend 3-hour cardiac amyloid radionuclide imaging (CARI) for transthyretin amyloid cardiomyopathy. Citing rapid blood clearance of 99m Tc-hydroxymethylene-diphosphonate (HMDP) and efficient laboratory throughput, 1-hour imaging is increasingly practiced despite limited supporting evidence. We sought to compare diagnostic performance and interpreter experience of 1-hour versus 3-hour HMDP-CARI. METHODS: Consecutive patients with suspected transthyretin amyloid cardiomyopathy (n=114) underwent both 1-hour and 3-hour HMDP single photon emission computed tomography (CT)/CT. Two cardiologist-radiologist reader teams, blinded to imaging timepoint (1 versus 3 hours), assessed overall interpretation, single photon emission CT–based Perugini grade, interpretation difficulty, interpreter confidence, and need for CT-fused images for anatomic localization. Discordant, equivocal, and difficult cases were arbitrated by a third tie-breaking team. The myocardial-to-blood-pool radiotracer uptake ratio (3-dimensional Score) was measured as a surrogate of contrast resolution. RESULTS: Interinterpreter agreement was high at both time points (κ≥0.81), with more cases requiring arbitration at 3 hours versus 1 hour (22% versus 13%; P =0.049). Overall interpretation and Perugini grades were concordant between time points in 111/114 (97%) and 106/114 (93%) patients, respectively. Three patients (3%) were negative at 1 hour but equivocal at 3 hours, all of which were clinically ruled out for transthyretin amyloid cardiomyopathy. Interpreter confidence was comparable at both timepoints (97% versus 95%; P =0.317). Compared with 3-hour imaging, contrast resolution was inferior (lower 3-dimensional score, P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CardiomyopathiesRadiopharmaceuticalsAmyloid Neuropathies, FamilialTechnetium Tc 99m MedronateSingle Photon Emission Computed Tomography Computed TomographyClinical CompetenceHumansFemaleMaleProspective StudiesAgedTime FactorsMiddle AgedPredictive Value of TestsReproducibility of ResultsObserver VariationAged, 80 and over

Stichwörter der Autor:innen

amyloidosiscardiomyopathiesradionuclide imagingtechnetiumworkflow

Substanzen

RadiopharmaceuticalsTechnetium Tc 99m Medronatetechnetium Tc 99m hydroxymethylene diphosphonate

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine (G.T., H.J., M.G.R.-P., J.W.A., J.P.B., K.A.Y., N.S.A., M.G., P. Chareonthaitawee, O.F.A.), Mayo Clinic, Rochester, MN.
  • Department of Internal Medicine (P. Carey), Mayo Clinic, Rochester, MN.
  • Mayo Clinic Alix School of Medicine, Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Rochester, MN (A.G.).
  • Department of Quantitative Health Sciences (C.G.S.), Mayo Clinic, Rochester, MN.
  • Department of Radiology (J.Z., F.J.M., L.F.K., C.B.H., G.B.J., J.P.B., N.S.A., A.C.H.), Mayo Clinic, Rochester, MN.
  • Division of Hematology, Department of Medicine (A.D.), Mayo Clinic, Rochester, MN.

ORCID-Profile: Gregorio Tersalvi, Patricia Carey, Armin Garmany, Christopher G Scott, Livia F Kruger, Carrie B Hruska, Geoffrey B Johnson, J Wells Askew, Kathleen A Young, Martha Grogan, Angela Dispenzieri, Panithaya Chareonthaitawee, Omar F AbouEzzeddine

Zitieren

APA

Tersalvi, G., Carey, P., Garmany, A., Scott, C. G., Zhang, J., Maldonado, F. J., Kruger, L. F., Hruska, C. B., Johnson, G. B., Jouni, H., Rodriguez-Porcel, M. G., Askew, J. W., Bois, J. P., Young, K. A., Anavekar, N. S., Grogan, M., Dispenzieri, A., Chareonthaitawee, P., Homb, A. C., & AbouEzzeddine, O. F. (2026). Diagnostic Performance and Interpreter Experience of 1-Hour Versus 3-Hour 99m Tc-HMDP Cardiac Amyloid Radionuclide Imaging: A Prospective, Blinded Comparison. Circulation: Cardiovascular Imaging. https://doi.org/10.1161/circimaging.125.018745

Vancouver

Tersalvi G, Carey P, Garmany A, Scott CG, Zhang J, Maldonado FJ, et al. Diagnostic Performance and Interpreter Experience of 1-Hour Versus 3-Hour 99m Tc-HMDP Cardiac Amyloid Radionuclide Imaging: A Prospective, Blinded Comparison. Circulation: Cardiovascular Imaging. 2026. doi:10.1161/circimaging.125.018745

BibTeX
@article{Tersalvi2026,
  author = {Tersalvi, Gregorio and Carey, Patricia and Garmany, Armin and Scott, Christopher G and Zhang, Jun and Maldonado, Francisco J and Kruger, Livia F and Hruska, Carrie B and Johnson, Geoffrey B and Jouni, Hayan and Rodriguez-Porcel, Martin G and Askew, J Wells and Bois, John P and Young, Kathleen A and Anavekar, Nandan S and Grogan, Martha and Dispenzieri, Angela and Chareonthaitawee, Panithaya and Homb, Andrew C and AbouEzzeddine, Omar F},
  title = {Diagnostic Performance and Interpreter Experience of 1-Hour Versus 3-Hour 99m Tc-HMDP Cardiac Amyloid Radionuclide Imaging: A Prospective, Blinded Comparison},
  journal = {Circulation: Cardiovascular Imaging},
  year = {2026},
  doi = {10.1161/circimaging.125.018745}
}
Kostenlos starten →